Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
N-(3-Chlorophenyl)-2-pyridinecarboxamide shows positive allosteric modulation at the mGlu4 receptors in combination with other antagonists resulting in treatment for the neurodegenerative Parkinson’s disease (1).
您的位置：
